U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.

Cover of StatPearls

StatPearls [Internet].

Show details

Histology, Kupffer Cell

; ; .

Author Information and Affiliations

Last Update: December 30, 2022.

Introduction

Kupffer cells (also known as stellate sinusoidal macrophages or Kupffer-Browicz cells) are macrophages found in the sinusoids of the liver. Kupffer cells make up 80% to 90% of all the macrophages in the entire human body.[1] They are a component of the host immune system and are involved in the metabolism of various compounds. Once thought to be related to endothelial cells, it is now known that the Kupffer cells descend from their own macrophage lineage, derived from the yolk sac rather than hematopoietic stem cells.[2]

Differentiation of Kupffer cells is regulated by macrophage colony-stimulating factors (M-CSFs) found in the serum and liver, as well as granulocyte-macrophage colony-stimulating factors (GM-CSFs).[3][4] Kupffer cells can be found in both the centrilobular and periportal regions of the liver, but they are typically more concentrated in the periportal regions. However, the cells in the two regions can differ in certain enzymes, receptors, and subcellular structures.[5]

Structure

Kupffer cells are specialized macrophages found in the hepatic sinusoid, along with sinusoidal endothelial cells, Ito cells, and pit cells.[6] Kupffer cells are amoeboid-shaped and are attached to the sinusoidal endothelial cells. [7] Their surface contains microvilli, pseudopodia, and lamellipodia, which can project out in all directions. The microvilli and pseudopodia are involved in the endocytosis of particles. They also contain the Golgi apparatus, ribosomes, centrioles, microfilaments, and microtubules in their cytoplasm.[8] Their nucleus is ovoid or indented and can be lobulated. They also contain rough endoplasmic reticulum, nuclear envelope, and annulate lamellae, which all have peroxidase activity.[9]

Kupffer cells' function and structure differ depending on their location in the centrilobular or periportal regions of the liver. Kupffer cells in the periportal regions tend to be larger, have more lysosomal enzyme activities, and have more phagocytic activity, while those in the centrilobular regions produce more superoxide anion.[10]

Function

The lifespan of a Kupffer cell is estimated to be 3.8 days.[11] The primary role of Kupffer cells is to clear foreign debris and particles from the portal system circulation that passes the liver. Kupffer cells can ingest large particles via phagocytosis and small particles and molecules via pinocytosis. It has also been shown that Kupffer cells can migrate to the portal areas and hepatic lymph nodes before they die.[12] In the liver, the population of Kupffer cells is constant, regulated by apoptosis, and phagocytized by neighboring Kupffer cells. In contrast to monocyte-derived macrophages with no proliferative potential, Kupffer cells have a proliferative capacity, allowing regeneration of themselves. In granuloma formation, Kupffer cells are activated without a supply of monocytes, transforming into multinuclear giant cells.[13]

The phagocytic ability of the Kupffer cells is vast; they can engulf pathogens, immune complexes, liposomes, lipid microspheres, tumor cells, endotoxins, and various other particles. Kupffer cells are also known to be heterogeneous in function based on their location. In zone 1 (periportal) of the liver lobules, they have higher activity overall than their counterpart in zone 3 (centrilobular).[10] The difference in activity is most likely due to the increased exposure to hazardous substances in zone 1 compared to zone 3. In addition to phagocytosis, Kupffer cells can produce inflammatory cytokines, oxygen radicals, TNF-alpha, and proteases; the production of these mediators is thought to contribute to the development of liver injury.[14]

Histochemistry and Cytochemistry

Kupffer cells stain positive for macrophage markers, including ED1, E2, and Ki-M2R in rats and F4/80 in mice. Their lysosomes stain positively for acid phosphatase. Kupffer cells can phagocytize other tracer substances, such as carbon, India ink, or latex microspheres, which are helpful in their identification.[15][16]

Microscopy, Light

Kupffer cells have a wide range of variability in cell size and shape and have elongated cytoplasmic processes. They are found along the sinusoid on top of the endothelium. They can be seen in contact with various cells, such as endothelial cells, fat-storing cells, collagen fibers, and other Kupffer cells.[6]

Microscopy, Electron

On electron microscopy, Kupffer cells can be seen adjacent to the sinusoid but not directly attached to the basement membrane. The microvilli from the parenchymal cells and the pseudopods of the Kupffer cells are intertwined.[8]

Pathophysiology

Kupffer cells are involved in the pathogenesis of liver injury in response to sepsis. The liver macrophages are activated and release IL-1 and TNF-alpha, which activate leukocytes and sinusoidal endothelial cells to express ICAM-1.[14] The result is tissue damage to the endothelium due to oxygen radicals, proteases, prostanoids, and other substances from leukocytes.[17]

Clinical Significance

Kupffer cells contain the SR-AI/II scavenger receptor, which is involved in recognizing and binding the lipid A domain of lipopolysaccharide (LPS) and lipoteichoic acid.[18] Lipopolysaccharide (LPS) is a bacterial endotoxin found in the cell wall of gram-negative bacteria, while lipoteichoic acid is found in gram-positive bacteria. Studies have found that mice lacking SR-AI/II receptors are more susceptible to infection from gram-positive bacteria, suggesting the importance of Kupffer cells in removing bacterial toxins from the system.[19]

Kupffer cells have been identified to play a key role in developing alcohol-induced liver disease. The intestinal tract of humans contains numerous bacteria, which can lead to the production of gut-derived endotoxin. The gut-derived endotoxins make their way to the liver, then cleared by the Kupffer cells. Studies suggest that these endotoxins activate Kupffer cells.[20] Several mechanisms have been proposed regarding the connection between endotoxin levels and alcoholic consumption. One example is that chronic alcohol use prevents Kupffer cells from effectively removing endotoxins from the blood, leading to increased circulating levels of endotoxins. Another mechanism states that alcohol consumption can lead to increased intestinal absorption of endotoxins through increased gut permeability. The endotoxin interacts with both Toll-like receptor 4 (TLR4) and CD14 receptors on Kupffer cells, signaling for the internalization of the lipopolysaccharide (LPS) endotoxin.[21] 

Kupffer cells activation results in the production of reactive oxygen species (ROS), such as superoxide, leading to oxidative stress in the liver. TLR4 activates interleukin-1 receptor-associated kinase (IRAK-1), which leads to the activation of nuclear factor kappa B (NF-kB).[20] The activation leads to numerous responses, which include the generation of superoxide and the production of cytokines; the end result is liver damage and, eventually, loss of liver function. Kupffer cell activation has also been implicated in developing binge drinking-induced fatty liver disease. The process is mediated by TNF-alpha activation of lipolysis. Kupffer cells can activate inflammasomes, which trigger the activation of caspase-1 and the production of IL-1beta, a pro-inflammatory mediator in alcoholic liver disease. Potential treatments for alcoholic liver disease are aimed at Kupffer cells’ role in the pathogenesis of the disease. Treatments for suppressing Kupffer cell activation and eliminating Kupffer cell cytotoxic products include antibiotics, probiotics, TNF-alpha inhibitors, and IL-1beta inhibitors.[22]

Kupffer cells have Fc, C3, and scavenger receptors involved in the phagocytosis of opsonized and nonopsonized materials.[23] Scavenger receptors are also involved in the deposition of cholesterol in arterial walls, leading to atherogenesis.[24] Also, Kupffer cells remove aged erythrocytes from circulation, resulting in elevated levels of heme oxygenase shortly after phagocytosis. Heme oxygenase is part of the metabolism and production of bilirubin; the enzyme degrades heme molecules in erythrocytes.[25]

Review Questions

Illustration of Hepatocyte Ultrastructure

Figure

Illustration of Hepatocyte Ultrastructure. Sinusoid of liver, Kupffer's Cell Contributed by Chelsea Rowe

References

1.
Chaudhry S, Emond J, Griesemer A. Immune Cell Trafficking to the Liver. Transplantation. 2019 Jul;103(7):1323-1337. [PMC free article: PMC7044802] [PubMed: 30817405]
2.
Gomez Perdiguero E, Klapproth K, Schulz C, Busch K, Azzoni E, Crozet L, Garner H, Trouillet C, de Bruijn MF, Geissmann F, Rodewald HR. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature. 2015 Feb 26;518(7540):547-51. [PMC free article: PMC5997177] [PubMed: 25470051]
3.
Yamamoto T, Kaizu C, Kawasaki T, Hasegawa G, Umezu H, Ohashi R, Sakurada J, Jiang S, Shultz L, Naito M. Macrophage colony-stimulating factor is indispensable for repopulation and differentiation of Kupffer cells but not for splenic red pulp macrophages in osteopetrotic (op/op) mice after macrophage depletion. Cell Tissue Res. 2008 May;332(2):245-56. [PubMed: 18335245]
4.
Li W, He F. Infusion of Kupffer Cells Expanded in Vitro Ameliorated Liver Fibrosis in a Murine Model of Liver Injury. Cell Transplant. 2021 Jan-Dec;30:9636897211004090. [PMC free article: PMC8020097] [PubMed: 33784833]
5.
Kolios G, Valatas V, Kouroumalis E. Role of Kupffer cells in the pathogenesis of liver disease. World J Gastroenterol. 2006 Dec 14;12(46):7413-20. [PMC free article: PMC4087584] [PubMed: 17167827]
6.
Wisse E, Braet F, Luo D, De Zanger R, Jans D, Crabbé E, Vermoesen A. Structure and function of sinusoidal lining cells in the liver. Toxicol Pathol. 1996 Jan-Feb;24(1):100-11. [PubMed: 8839287]
7.
Naito M, Hasegawa G, Ebe Y, Yamamoto T. Differentiation and function of Kupffer cells. Med Electron Microsc. 2004 Mar;37(1):16-28. [PubMed: 15057601]
8.
Sichel G, Scalia M, Corsaro C. Amphibia Kupffer cells. Microsc Res Tech. 2002 Jun 15;57(6):477-90. [PubMed: 12112430]
9.
Wisse E. Observations on the fine structure and peroxidase cytochemistry of normal rat liver Kupffer cells. J Ultrastruct Res. 1974 Mar;46(3):393-426. [PubMed: 4363811]
10.
Campion SN, Tatis-Rios C, Augustine LM, Goedken MJ, van Rooijen N, Cherrington NJ, Manautou JE. Effect of allyl alcohol on hepatic transporter expression: zonal patterns of expression and role of Kupffer cell function. Toxicol Appl Pharmacol. 2009 Apr 01;236(1):49-58. [PMC free article: PMC4404030] [PubMed: 19371622]
11.
Nguyen-Lefebvre AT, Horuzsko A. Kupffer Cell Metabolism and Function. J Enzymol Metab. 2015;1(1) [PMC free article: PMC4771376] [PubMed: 26937490]
12.
Hardonk MJ, Dijkhuis FW, Grond J, Koudstaal J, Poppema S. Evidence for a migratory capability of rat Kupffer cells to portal tracts and hepatic lymph nodes. Virchows Arch B Cell Pathol Incl Mol Pathol. 1986;51(5):429-42. [PubMed: 2876547]
13.
Yamada M, Naito M, Takahashi K. Kupffer cell proliferation and glucan-induced granuloma formation in mice depleted of blood monocytes by strontium-89. J Leukoc Biol. 1990 Mar;47(3):195-205. [PubMed: 2307905]
14.
Roberts RA, Ganey PE, Ju C, Kamendulis LM, Rusyn I, Klaunig JE. Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicol Sci. 2007 Mar;96(1):2-15. [PubMed: 17122412]
15.
Elchaninov AV, Fatkhudinov TK, Vishnyakova PA, Lokhonina AV, Sukhikh GT. Phenotypical and Functional Polymorphism of Liver Resident Macrophages. Cells. 2019 Sep 05;8(9) [PMC free article: PMC6769646] [PubMed: 31491903]
16.
Fujita H, Kawamata S, Yamashita K. Electron microscopic studies on multinucleate foreign body giant cells derived from Kupffer cells in mice given Indian ink intravenously. Virchows Arch B Cell Pathol Incl Mol Pathol. 1983;42(1):33-42. [PubMed: 6132487]
17.
Gulubova MV. Intercellular adhesion molecule-1 (ICAM-1) expression in the liver of patients with extrahepatic cholestasis. Acta Histochem. 1998 Feb;100(1):59-74. [PubMed: 9542581]
18.
van Oosten M, van Amersfoort ES, van Berkel TJ, Kuiper J. Scavenger receptor-like receptors for the binding of lipopolysaccharide and lipoteichoic acid to liver endothelial and Kupffer cells. J Endotoxin Res. 2001;7(5):381-4. [PubMed: 11753207]
19.
Thomas CA, Li Y, Kodama T, Suzuki H, Silverstein SC, El Khoury J. Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis. J Exp Med. 2000 Jan 03;191(1):147-56. [PMC free article: PMC2195800] [PubMed: 10620613]
20.
Luedde T, Schwabe RF. NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2011 Feb;8(2):108-18. [PMC free article: PMC3295539] [PubMed: 21293511]
21.
Ciesielska A, Matyjek M, Kwiatkowska K. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell Mol Life Sci. 2021 Feb;78(4):1233-1261. [PMC free article: PMC7904555] [PubMed: 33057840]
22.
Chen W, Zhang J, Fan HN, Zhu JS. Function and therapeutic advances of chemokine and its receptor in nonalcoholic fatty liver disease. Therap Adv Gastroenterol. 2018;11:1756284818815184. [PMC free article: PMC6295708] [PubMed: 30574191]
23.
Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int. 2006 Dec;26(10):1175-86. [PubMed: 17105582]
24.
van Oosten M, van de Bilt E, van Berkel TJ, Kuiper J. New scavenger receptor-like receptors for the binding of lipopolysaccharide to liver endothelial and Kupffer cells. Infect Immun. 1998 Nov;66(11):5107-12. [PMC free article: PMC108636] [PubMed: 9784510]
25.
Hirano K, Kobayashi T, Watanabe T, Yamamoto T, Hasegawa G, Hatakeyama K, Suematsu M, Naito M. Role of heme oxygenase-1 and Kupffer cells in the production of bilirubin in the rat liver. Arch Histol Cytol. 2001 May;64(2):169-78. [PubMed: 11436987]

Disclosure: Hajira Basit declares no relevant financial relationships with ineligible companies.

Disclosure: Michael Tan declares no relevant financial relationships with ineligible companies.

Disclosure: Daniel Webster declares no relevant financial relationships with ineligible companies.

Copyright © 2024, StatPearls Publishing LLC.

This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.

Bookshelf ID: NBK493226PMID: 29630278

Views

  • PubReader
  • Print View
  • Cite this Page

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Similar articles in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...